Area:
General Psychology, General, Physiological Psychology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Denise Hien is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2008 — 2011 |
Hien, Denise Aimee |
R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
A Randomized Trial of Concurrent Treatment For Ptsd and Substance Dependence @ City College of New York
DESCRIPTION (provided by applicant): Nearly two decades of epidemiological and clinical studies have documented the staggering rates of comorbidity between trauma exposure and substance use, as well as the high rates of PTSD comorbidity. However, treatments which effectively address these complex symptoms are still at an early stage of development. This study will enhance the knowledge and understanding of concurrently treating individuals with substance use disorders and PTSD in hopes of facilitating treatment retention and increasing the likelihood for more positive treatment outcomes. Following NIDA's stage model for behavior therapies development, this study will take the next step building upon promising findings from Stage IA work with an exposure-based therapy modified to use safely with substance dependent individuals. The first aim of this Stage1B clinical trial is to modify and test an exposure-based treatment for individuals with substance use disorder and comorbid PTSD. Using a two-armed randomized design, the proposed clinical trial will assess the relative efficacy of: 1) Concurrent Treatment of PTSD and Substance Dependence (CTPSD) which incorporates exposure techniques with CBT, and 2) Relapse Prevention Treatment (RPT). Participants will be recruited from the greater New York City area, with study procedures taking place at St. Luke's\Roosevelt Hospital Center. Treatment will consist of 12 individual sessions with repeated measures at baseline, end of treatment, and 1-, 2- and 3-months post-treatment. The primary outcome is PTSD symptom severity. Secondary outcomes are (2a) substance abuse severity, (2b) global psychiatric symptom severity, and (2c) treatment retention and compliance. The third exploratory aim of the proposed trial is to test the potential mechanisms of action in the respective treatments. Based on findings regarding the neurobiology of trauma, we hypothesize that emotion regulation and related physiological processes are predictive of treatment outcome. We will test for mediator and moderator effects using both subjective (self-report) and objective (electrodermal skin fluctuation) measures. The fourth exploratory aim of the proposed trial is to explore pathways between the comorbid PTSD and SUD diagnoses and how they may change through the course of treatment. The proposed study has the particular advantages of building directly on positive preliminary Stage IA empirical findings by (1) further testing exposure therapy in individuals with PTSD and SUDs using a randomized design with an active treatment comparison group, (2) measuring emotion regulation and physiological arousal with both subjective and objective measures, as well as measuring PTSD and SUD outcomes, and (3) utilizing a multi-disciplinary team of experts who have successfully collaborated in the past and are uniquely qualified to design and implement this type of investigation.
|
0.928 |
2013 — 2021 |
Hien, Denise Aimee |
R25Activity Code Description: For support to develop and/or implement a program as it relates to a category in one or more of the areas of education, information, training, technical assistance, coordination, or evaluation. |
Translational Research Training On Addictions For Racial/Ethnic Minorities @ City College of New York
DESCRIPTION (provided by applicant): This proposed research training program, Translational research training in addictions for racial/ethnic minorities at City College of New York (CCNY) and Columbia University Medical Center (CUMC) or TRACC, is designed to increase the number of interdisciplinary scientists capable to serve as Principal Investigators (PIs) on extramurally funded studies in drug abuse research from underrepresented racial/ethnic minority (REM) groups, still identified as a pressing public health need. As the fiel of translational neuroscience continues to expand exponentially, the number of qualified REM scientists trained with knowledge of basic science as it relates to real world treatment needs in the addictions community lags behind. This proposal focuses on addressing these gaps through an innovative interdisciplinary research training and mentoring program that will reach earlier into the career development pipeline to identify the most talented M.A.-, B.S./M.D.- and Ph.D.-level REM students from psychology (cognitive neuroscience and clinical) and medical school (B.S./M.D.) programs at an urban, public minority serving institution [City College of New York (CCNY)]. The applied research training program will be supported by the mentorship of committed leaders in the field of drug abuse research at CCNY, partnered with prominent faculty from the Division on Substance Abuse at Columbia University Medical Center (CUMC). Overarching outcomes for TRACC trainees include: 1) obtaining knowledge about key neuroscience research (questions and approaches) in the context of community treatment in drug abuse; 2) conducting an honors level substance abuse-related research project; 3) presenting a paper or poster at a local or national conference; 4) authoring or co-authoring a scientific journal article; 5) preparing an application for a training grant award to an APA or NIH mechanism funding program and; 6) developing research self-efficacy.
|
0.928 |